The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
Clinical trial NCT06362720 · UNKNOWN
Trial details
- NCT number
- NCT06362720
- Sponsor
- Siriraj Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-01
- Primary completion
- 2024-10-31
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.